Anumana is an AI-driven health technology company committed to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana is developing software-as-a-medical-device (SaMD) solutions that apply multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care.

The company’s developing portfolio includes ECG-based algorithms, generative imaging applications, and real-time procedural support tools designed to improve outcomes in both diagnostic and intraprocedural settings. The company’s FDA-cleared ECG-AI® LEF, ECG-AI® CA, and ECG-AI® PH algorithms are currently available in the U.S and are eligible for reimbursement under CPT codes for AI-based ECG analysis to assess cardiac dysfunction. Please visit www.anumana.ai for more information and follow Anumana on LinkedIn for company updates.